Record Q2 revenue and profitability exceeded guidance, driven by strong MACI and Burn Care growth. Full-year guidance was raised, a $200 million share repurchase was announced, and significant cash generation supports ongoing investments and capital returns.Based on Vericel Corporation [VCEL] Q2 20…
Record Q2 revenue and profit exceeded guidance, driven by strong MACI and Burn Care growth. Full-year guidance was raised, a $200 million share repurchase was announced, and significant progress was made on U.K. expansion and clinical initiatives.Based on Vericel Corporation [VCEL] Q2 2026 Audio Tr…
Vericel reported second-quarter 2026 total net revenue of $77.5 million, up 22% year-over-year, with MACI revenue of $65.5 million and gross profit of $56.4 million (73% margin). The company posted net income of $2.2 million (diluted EPS $0.04) and adjusted EBITDA of $14.9 million for the quarter…
Record Q2 revenue grew 22% year-over-year, led by 23% MACI and 22% Burn Care growth. Net income turned positive, free cash flow surged, and full-year guidance was raised. Board authorized a $200M share repurchase program.Original document: Vericel Corporation [VCEL] Slides Release — Jul. 30 2026Thi…
